Drugs / Alda-341
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04296266 | Feb 2016 → Dec 2017 | parotid gland neoplasm, submandibular gland neoplasm | Stanford University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alda-341 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04296266 ↗ |